You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Ta strona internetowa używa plików cookie

Kontynuując korzystanie z tej strony internetowej, wyrażasz zgodę na korzystanie z plików cookie. Więcej informacji o plikach cookie i sposobie ich używania można znaleźć w naszej Polityce prywatności.

ISICEM 2020

40th International Symposium on Intensive Care and Emergency Medicine - postponed to September 2020

Brussels, Belgium września 15 - 18

This year is the 40th edition of the ISICEM congress: over the years, the congress has become a reference within the intensive care medicine world and is a must attend event for more than 6,000 participants.

Please notice: In view of the current situation, the 40th ISICEM has been postponed by 6 months and will take place in September 2020.

Dane wydarzenia

Data: września 15 - 18
Miejscowość: Brussels, Belgium
Lokalizacja: Square - Brussels Convention Center
Stoisko: 2.32 - 2.35

Zobacz stronę internetową wydarzenia

Getinge symposium

Getinge lunch symposia

Getinge will also take part to the scientific program of the event by offering two sponsored lunch symposia to the congress attendees on Wednesday, September 16 and Thursday, September 17 from 12:30 to 13:30.

Advanced technologies to manage severe patients

Date: Wednesday, September 16, 2020 
Time: 12:30 – 13:30
Venue: Silver Hall

Chairperson: Fernando Suarez Sipmann (Madrid, Spain)

  • Lung recruitment: can automation and enhanced monitoring improve safety and efficacy?
    Fernando Suarez Sipmann (Madrid, Spain)
  • Avoidance of fluid overload
    Manu Malbrain (Brussels, Belgium)
  • ECMO for acute myocardial infarction cardiogenic shock: the ANCHOR trial
    Alain Combes (Paris, France)

Challenges and solutions in the treatment of COPD patients

Date: Thursday, September 17, 2020 

Time: 12:30 – 13:30
Venue: Silver Hall

Chairperson: Ewan Goligher (Toronto, Canada)

  • NIV NAVA: Monitoring effort and enhancing synchrony to avoid intubation
    Ewan Goligher (Toronto, Canada)
  • Can transpulmonary thermodilution benefit COPD patients during weaning?
    Xavier Monnet (Paris, France)
  • CO2 removal for COPD patients
    Marco Ranieri (Bologna, Italy)

Simulation center 2020

We are excited to offer you the chance to take part in an interactive, hands-on learning experience in the Simulation center.

  • Presentation and interactive discussion of a challenging case from one of three clinical scenarios: Septic shock, ARDS, use of ECMO
  • Hands-on experience of monitoring devices relevant to each clinical scenario
  • Critical appraisal of therapeutic strategies relevant to each clinical scenario
  • Consideration of how to individualize therapy in light of results from large RCTs

Each Session will last 45 minutes and include 1 case presenter, 1 expert and a maximum of 10 participants.

View the Simulation center schedule here

PulsioFlex Monitor

Modular platform with intelligent visualization for advanced patient monitoring

Dowiedz się więcej o PulsioFlex Monitor

Early Protective Mechanical Ventilation is key to ARDS outcomes

The Lungsafe study demonstrated that protective ventilation is not consistently applied, reflecting the need for more accessible and effective bedside tools for identification of the lung at risk [1]. This important study concluded that ARDS is underrecognized, undertreated, and still associated with a high mortality rate.

Dowiedz się więcej o ARDS - Mechanical Ventilation

ECLS can be a life-saver for ARDS patients

Despite advances in treatment options, mortality and morbidity in patients with acute respiratory distress syndrome (ARDS) remain high. Extracorporeal membrane oxygenation (ECMO) has emerged as a promising intervention. [1] Improvements in technology have made ECMO safer and easier to use, allowing for the potential of more patients with ARDS receiving this therapy.

Dowiedz się więcej o ECMO for ARDS

NICCI Technology

NICCI is the latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights. NICCI helps guiding individual treatment decisions by reliably providing dynamic parameters, such as mean arterial pressure (MAP), cardiac index (CI), stroke volume variation (SVV) and pulse pressure variation (PPV). *The availability of NICCI depends on regional regulatory approval status

Dowiedz się więcej o NICCI Technology